Cargando…
Targeting the TGF-β1 Pathway to Prevent Normal Tissue Injury After Cancer Therapy
With >10,000,000 cancer survivors in the U.S. alone, the late effects of cancer treatment are a significant public health issue. Over the past 15 years, much work has been done that has led to an improvement in our understanding of the molecular mechanisms underlying the development of normal tis...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AlphaMed Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227962/ https://www.ncbi.nlm.nih.gov/pubmed/20413640 http://dx.doi.org/10.1634/theoncologist.2009-S101 |